DEPLOYDatabase

Deployment

Cyberdyne HAL at United States

Powered (motor-driven) exoskeleton whose distinguishing feature is bioelectric-signal control: skin-surface sensors detect the faint nerve/muscle signals of intended movement and drive the actuators in sync. Medical lower-limb version FDA cleared 2017; clinical use in Japan since 2008.

Cyberdyne HAL by Cyberdyne · Operated by Cyberdyne · Catalog entry · 2 sources · not yet field-verified · Exoskeletons

Track Cyberdyne HAL at United States

Recent coverage

See all coverage →

Machine-readable surfaces

Cyberdyne operates fee-based medical HAL services in the US through subsidiary RISE Healthcare Group at 5 Southern California locations. FDA clearance covers SCI, stroke, progressive neuromuscular diseases, and cerebral palsy (ages 12+). Carnegie Mellon University MOU signed December 2025 to accelerate US social implementation.

Key facts

FDA status
FDA cleared for SCI, stroke, 8 progressive neuromuscular diseases, cerebral palsy (ages 12+), HAM, hereditary spastic paraplegia
US clinical sites
RISE Healthcare Group operates 5 fee-based medical locations in Southern California
CMU partnership
Strategic MOU with Carnegie Mellon University signed December 2025 for US social implementation

Safety record

No incidents on record for Cyberdyne HAL at United States.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Trust tier
Catalog entry · 2 sources · not yet field-verifiedhow tiers work →
Last updated
2026-07-10
Model
Cyberdyne HAL
Company
Cyberdyne
Location
United States
Operator
Cyberdyne
Status
operational
Operator type
maker operated
ID
0c08a628-e850-46cf-8942-fdf91fcc9e05

Timeline

  1. Jun 2026
    created
  2. Jul 2026
    Current status: operational, reviewed
    Latest recorded state. New status transitions append here as the deployment-status recorder produces them.

On the deployment map

Cyberdyne HAL operates in United States. Explore the full verified map:

Sources (2)

  1. https://www.cyberdyne.jp/english/company/PressReleases_detail.html?id=14303
  2. https://www.fda.gov/medical-devices/recently-approved-devices/cyberdyne-hal-510k
Methodology: Verified · 2 sources (1 primary) · last reviewed 2026-07-10

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-07-10

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: exoskeleton

Sources by quality tier

1
unclassified
Unclassified source
1
primary-fda-database
FDA database

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Cyberdyne HAL at United States.

Common questions

What is the Cyberdyne HAL deployment at United States?
Cyberdyne HAL, built by Cyberdyne, is recorded as a deployment at United States on the DEPLOY registry. Cyberdyne operates the deployment directly.
Who operates Cyberdyne HAL at United States?
Cyberdyne, the manufacturer of Cyberdyne HAL, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
Have there been incidents at the Cyberdyne HAL deployment at United States?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.